Silencing expression of UO-44 (CUZD1) using small interfering RNA sensitizes human ovarian cancer cells to cisplatin in vitro.

Abstract:

:Ovarian cancer is currently the second leading cause of gynecological malignancy and cisplatin or cisplatin-based regimens have been the standard of care for the treatment of advance epithelial ovarian cancers. However, the efficacy of cisplatin treatment is often limited by the development of drug resistance either through the inhibition of apoptotic genes or activation of antiapoptotic genes. We have previously reported the overexpression of human UO-44 (HuUO-44) in ovarian cancers and the HuUO-44 antisera markedly inhibited NIH-OVCAR3 ovarian cancer cell attachment and proliferation (Oncogene 23: 5707-5718, 2004). In the present study, we observed through the cancer cell line profiling array that the expression of HuUO-44 was suppressed in the ovarian cancer cell line (SKOV-3) after treatment with several chemotherapeutic drugs. Similarly, this suppression in HuUO-44 expression was also correlated to the cisplatin sensitivity in two other ovarian cancer cell lines NIH-OVCAR3 and OV-90 in a dose-dependent manner. To elucidate the function of HuUO-44 in cisplatin chemoresistance in ovarian cancer cell, small interfering RNAs (siRNAs) were employed to mediate HuUO-44 silencing in ovarian cancer cell line, NIH-OVCAR3. HuUO-44 RNA interference (RNAi) resulted in the inhibition of cell growth and proliferation. Importantly, HuUO-44 RNAi significantly increased sensitivity of NIH-OVCAR3 to cytotoxic stress induced by cisplatin (P<0.01). Strikingly, we have also demonstrated that overexpression of HuUO-44 significantly conferred cisplatin resistance in NIH-OVCAR3 cells (P<0.05). Taken together, UO-44 is involved in conferring cisplatin resistance; the described HuUO-44-specific siRNA oligonucleotides that can potently silence HuUO-44 gene expression may prove to be valuable pretreatment targets for antitumor therapy or other pathological conditions that involves aberrant HuUO-44 expression.

journal_name

Oncogene

journal_title

Oncogene

authors

Leong CT,Ong CK,Tay SK,Huynh H

doi

10.1038/sj.onc.1209836

subject

Has Abstract

pub_date

2007-02-08 00:00:00

pages

870-80

issue

6

eissn

0950-9232

issn

1476-5594

pii

1209836

journal_volume

26

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • SCF-mediated protein degradation and cell cycle control.

    abstract::The regulatory step in ubiquitin (Ub)-mediated protein degradation involves recognition and selection of the target substrate by an E3 Ub-ligase. E3 Ub-ligases evoke sophisticated mechanisms to regulate their activity temporally and spatially, including multiple post-translational modifications, combinatorial E3 Ub-li...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1208614

    authors: Ang XL,Wade Harper J

    更新日期:2005-04-18 00:00:00

  • Overexpression confers an oncogenic potential upon the eph gene.

    abstract::The eph gene encodes a putative receptor tyrosine kinase for an as yet unknown ligand. Some human cancer cells have been found to overexpress eph mRNAs without gene amplification. We show here that NIH3T3 cells acquire tumorigenic ability in nude mice and make colonies in soft agar with a viral LTR (Long Terminal Repe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Maru Y,Hirai H,Takaku F

    更新日期:1990-03-01 00:00:00

  • Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer.

    abstract::Our recent study showed critical roles of Dmp1 as a sensor of oncogenic Ras, HER2/neu signaling and activation of the Arf-p53 pathway. To elucidate the role of human DMP1 (hDMP1) in breast cancer, one hundred and ten pairs of human breast cancer specimen were studied for the alterations of the hDMP1-ARF-Hdm2-p53 pathw...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.423

    authors: Maglic D,Zhu S,Fry EA,Taneja P,Kai F,Kendig RD,Sugiyama T,Miller LD,Willingham MC,Inoue K

    更新日期:2013-08-29 00:00:00

  • Identification of a dominant-negative mutation in the yeast CDC25 guanine nucleotide exchange factor for Ras.

    abstract::In previous studies we changed five conserved amino acid residues in the catalytic domain of the yeast Ras-specific guanine nucleotide exchange factor CDC25GEF (Park et al., 1994). One of the substitutions (R1489E) resulted in a molecule which could bind Ras but was catalytically inactive. These observations suggested...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1200893

    authors: Park W,Mosteller RD,Broek D

    更新日期:1997-02-20 00:00:00

  • Identification of heterologous translocation partner genes fused to the BCL6 gene in diffuse large B-cell lymphomas: 5'-RACE and LA - PCR analyses of biopsy samples.

    abstract::In order to elucidate the molecular mechanism(s) for BCL6 translocation, we identified translocational partner genes by subjecting clinical biopsy samples from patients with non-Hodgkin's lymphoma to 5'-rapid amplification of cDNA ends (5'-RACE). Sequence analysis of the 5'-RACE product revealed that the BCL6 gene was...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203293

    authors: Yoshida S,Kaneita Y,Aoki Y,Seto M,Mori S,Moriyama M

    更新日期:1999-12-23 00:00:00

  • The DNA-damage response and nuclear events as regulators of nonapoptotic forms of cell death.

    abstract::The maintenance of genome stability is essential for the cell as the integrity of genomic information guaranties reproduction of a whole organism. DNA damage occurring in response to different natural and nonnatural stimuli (errors in DNA replication, UV radiation, chemical agents, etc.) is normally detected by specia...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/s41388-019-0980-6

    authors: Prokhorova EA,Egorshina AY,Zhivotovsky B,Kopeina GS

    更新日期:2020-01-01 00:00:00

  • Transcriptional and post-transcriptional induction of the TGFalpha gene in transformed rat liver epithelial cells.

    abstract::Although TGFalpha mRNA and protein are frequently elevated in neoplastic cells, neither the level at which deregulation occurs nor the mechanism(s) responsible have been well characterized. As a first step, we examined the induction of TGFalpha mRNA in two series of clonally-derived rat liver epithelial cell lines tha...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Berkowitz EA,Hissong MA,Lee DC

    更新日期:1996-05-02 00:00:00

  • Cdc25B activity is regulated by 14-3-3.

    abstract::In the G2 phase cell cycle checkpoint arrest, the cdc25-dependent activation of cyclin B/cdc2, a critical step in regulating entry into mitosis, is blocked. Studies in yeast have demonstrated that the inhibition of cdc25 function involves 14-3-3 binding to cdc25. In humans, two cdc25 isoforms have roles in G2/M progre...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204574

    authors: Forrest A,Gabrielli B

    更新日期:2001-07-19 00:00:00

  • AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy.

    abstract::The phosphatidylinositol 3-kinase (PI3K)/AKT and RAS oncogenic signalling modules are frequently mutated in sporadic human cancer. Although each of these pathways has been shown to play critical roles in driving tumour growth and proliferation, their activation in normal human cells can also promote cell senescence. A...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.394

    authors: Astle MV,Hannan KM,Ng PY,Lee RS,George AJ,Hsu AK,Haupt Y,Hannan RD,Pearson RB

    更新日期:2012-04-12 00:00:00

  • Regulation of DNA binding by Rel/NF-kappaB transcription factors: structural views.

    abstract::Rel/NF-kappaB transcription factors form homo- and heterodimers with different DNA binding site specificities and DNA binding affinities. Several intracellular pathways evoked by a wide range of biological factors and environmental conditions can lead to the activation of Rel/NF-kappaB dimers by signaling degradation ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1203224

    authors: Chen FE,Ghosh G

    更新日期:1999-11-22 00:00:00

  • Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis.

    abstract::Familial adenomatous polyposis (FAP) is caused by germline mutations in the adenomatous polyposis coli (APC) gene. Two promoters, 1A and 1B, have been recognized in APC, and 1B is thought to have a minor role in the regulation of the gene. We have identified a novel deletion encompassing half of this promoter in the l...

    journal_title:Oncogene

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1038/onc.2011.201

    authors: Rohlin A,Engwall Y,Fritzell K,Göransson K,Bergsten A,Einbeigi Z,Nilbert M,Karlsson P,Björk J,Nordling M

    更新日期:2011-12-15 00:00:00

  • A comprehensive profile of recurrent glioblastoma.

    abstract::In spite of relentless efforts to devise new treatment strategies, primary glioblastomas invariably recur as aggressive, therapy-resistant relapses and patients rapidly succumb to these tumors. Many therapeutic agents are first tested in clinical trials involving recurrent glioblastomas. Remarkably, however, fundament...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2016.85

    authors: Campos B,Olsen LR,Urup T,Poulsen HS

    更新日期:2016-11-10 00:00:00

  • Functional genomics identifies new synergistic therapies for retinoblastoma.

    abstract::Local intravitreal or intra-arterial chemotherapy has improved therapeutic success for the pediatric cancer retinoblastoma (RB), but toxicity remains a major caveat. RB initiates primarily with RB1 loss or, rarely, MYCN amplification, but the critical downstream networks are incompletely understood. We set out to unco...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-1372-7

    authors: Aubry A,Pearson JD,Huang K,Livne-Bar I,Ahmad M,Jagadeesan M,Khetan V,Ketela T,Brown KR,Yu T,Lu S,Wrana JL,Moffat J,Bremner R

    更新日期:2020-07-01 00:00:00

  • Mutational analysis of conserved residues in the tyrosine kinase domain of the human trk oncogene.

    abstract::The human trk oncogene (originally identified in a colon carcinoma) was activated by a genetic rearrangement which resulted in replacement of the extracellular ligand-binding domain of the proto-trk transmembrane receptor by non-muscle tropomyosin sequences. The product of the trk oncogene, a protein of 70 kDa (p70trk...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Mitra G

    更新日期:1991-12-01 00:00:00

  • hPMC2 is required for recruiting an ERbeta coactivator complex to mediate transcriptional upregulation of NQO1 and protection against oxidative DNA damage by tamoxifen.

    abstract::In the presence of ERbeta, trans-hydroxytamoxifen (TOT) protects cells against 17beta-estradiol (E(2))-induced oxidative DNA damage (ODD) and this correlates with increased expression of the antioxidative enzyme quinone reductase (QR). Here, we investigate the molecular mechanism responsible for ERbeta-mediated protec...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.235

    authors: Sripathy SP,Chaplin LJ,Gaikwad NW,Rogan EG,Montano MM

    更新日期:2008-10-23 00:00:00

  • α-Catulin knockdown induces senescence in cancer cells.

    abstract::Cellular senescence functions as a tumor suppressor that protects against cancer progression. α-Catulin, an α-catenin-related protein, is reported to have tumorigenic potential because it regulates the nuclear factor-κB (NF-κB) pathway, but little is known about its clinical relevance and the mechanism through which i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.637

    authors: Fan LC,Chiang WF,Liang CH,Tsai YT,Wong TY,Chen KC,Hong TM,Chen YL

    更新日期:2011-06-09 00:00:00

  • MAGEA1 interacts with FBXW7 and regulates ubiquitin ligase-mediated turnover of NICD1 in breast and ovarian cancer cells.

    abstract::Melanoma-associated antigen A1 (MAGEA1) is member of the MAGE gene family that is expressed in male germ line cells and placenta under normal physiological conditions. Although MAGEA1's expression levels have been evaluated as one of the cancer testis (CT) antigens for immunotherapy in melanoma and several other cance...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.131

    authors: Zhao J,Wang Y,Mu C,Xu Y,Sang J

    更新日期:2017-08-31 00:00:00

  • Identification of a novel fusion gene involving hTAFII68 and CHN from a t(9;17)(q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma.

    abstract::A proportion of extraskeletal myxoid chondrosarcomas (EMC) have been shown to have a characteristic translocation t(9;22)(q22;q12) involving the EWS gene at 22q12 and the CHN orphan nuclear receptor gene at 9q22. This translocation appears to be largely specific for EMC, but has not been detected in all such tumours. ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203156

    authors: Attwooll C,Tariq M,Harris M,Coyne JD,Telford N,Varley JM

    更新日期:1999-12-09 00:00:00

  • Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma.

    abstract::Germline BAP1 mutations predispose to several cancers, in particular malignant mesothelioma. Mesothelioma is an aggressive malignancy generally associated with professional exposure to asbestos. However, to date, we found that none of the mesothelioma patients carrying germline BAP1 mutations were professionally expos...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.243

    authors: Napolitano A,Pellegrini L,Dey A,Larson D,Tanji M,Flores EG,Kendrick B,Lapid D,Powers A,Kanodia S,Pastorino S,Pass HI,Dixit V,Yang H,Carbone M

    更新日期:2016-04-14 00:00:00

  • S6K1 determines the metabolic requirements for BCR-ABL survival.

    abstract::In chronic myelogenous leukemia, the constitutive activation of the BCR-ABL kinase transforms cells to an addicted state that requires glucose metabolism for survival. We investigated S6K1, a protein kinase that drives glycolysis in leukemia cells, as a target for counteracting glucose-dependent survival induced by BC...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.70

    authors: Barger JF,Gallo CA,Tandon P,Liu H,Sullivan A,Grimes HL,Plas DR

    更新日期:2013-01-24 00:00:00

  • Snail is a repressor of RKIP transcription in metastatic prostate cancer cells.

    abstract::Diminished expression of the metastasis suppressor protein RKIP was previously reported in a number of cancers. The underlying mechanism remains unknown. Here, we show that the expression of RKIP negatively correlates with that of Snail zinc-transcriptional repressor, a key modulator of normal and neoplastic epithelia...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210860

    authors: Beach S,Tang H,Park S,Dhillon AS,Keller ET,Kolch W,Yeung KC

    更新日期:2008-04-03 00:00:00

  • Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2.

    abstract::Cancer cells recruit monocytes, macrophages and other inflammatory cells by producing abundant chemoattractants and growth factors, such as macrophage colony-stimulating factor (M-CSF/CSF-1) and monocyte chemoattractant protein-1 (MCP-1/CCL2), to promote tumor growth and dissemination. An understanding of the mechanis...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.112

    authors: Li Y,Cai L,Wang H,Wu P,Gu W,Chen Y,Hao H,Tang K,Yi P,Liu M,Miao S,Ye D

    更新日期:2011-09-08 00:00:00

  • Activation-dependent degradation of protein kinase C eta.

    abstract::Prolonged activation of protein kinase Cs (PKCs) by long-term treatment of cells with phorbol ester tumor promoters down-regulates the expression of many PKCs. To investigate the molecular mechanisms involved in the down-regulation of PKC eta, we expressed the novel PKCs eta and θ and various mutant forms in bab...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203779

    authors: Kang BS,French OG,Sando JJ,Hahn CS

    更新日期:2000-08-31 00:00:00

  • Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells.

    abstract::The rodent S100-related calcium-binding protein, S100A4 induces metastasis in non-metastatic rat and mouse benign mammary cells and co-operates with benign-tumour-inducing changes in two transgenic mouse models, to yield metastatic mammary tumours. Co-transfection of the human gene for S100A4 with pSV2neo into the ben...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201948

    authors: Lloyd BH,Platt-Higgins A,Rudland PS,Barraclough R

    更新日期:1998-07-30 00:00:00

  • FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A.

    abstract::Prostate cancer (PCa) growth is dependent on androgens and on the androgen receptor (AR), which acts by modulating gene transcription. Tetratricopeptide repeat (TPR) proteins (FKBP52, FKBP51 and Cyp40) interact with AR in PCa cells, suggesting roles in AR-mediated gene transcription and cell growth. We report here tha...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.458

    authors: Periyasamy S,Hinds T Jr,Shemshedini L,Shou W,Sanchez ER

    更新日期:2010-03-18 00:00:00

  • Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma.

    abstract::A lot of attention has been dedicated to investigate the role of the tyrosine kinase receptor MET in tumors. The acquired notion that cancer cells from different histological origin strictly rely on the engagement of this specific oncogene for their growth and survival has certainly justified the development and the u...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2016.36

    authors: Finisguerra V,Prenen H,Mazzone M

    更新日期:2016-10-20 00:00:00

  • Simple sequence repeat polymorphism within the p53 gene.

    abstract::This report describes a new polymorphism, in intron 3 of the p53 gene, which consists of a single repeat of 16 nucleotides, absent in the published wild-type p53 gene sequence. In the Caucasian population tested (n = 82), 28% of individuals were heterozygotes for this polymorphism. Using PCR-based analysis, we were ab...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Lazar V,Hazard F,Bertin F,Janin N,Bellet D,Bressac B

    更新日期:1993-06-01 00:00:00

  • MicroRNAs as potential cancer therapeutics.

    abstract::MicroRNAs (miRNAs) have been shown to have an important role in various cellular processes, such as apoptosis, differentiation and development. Recent studies have shown that miRNAs are mis-expressed in human cancers where they can exert their effect as oncogenes or tumor suppressors. Here, we review the potential for...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2009.353

    authors: Trang P,Weidhaas JB,Slack FJ

    更新日期:2008-12-01 00:00:00

  • Mimicking the BH3 domain to kill cancer cells.

    abstract::Cancer cells show deviant behavior that induces apoptotic signaling. To survive, cancer cells typically acquire changes enabling evasion of death signals. One way they do this is by increasing the expression of anti-apoptotic BCL-2 proteins. Anti-apoptotic BCL-2 family proteins antagonize death signaling by forming he...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2009.52

    authors: Ni Chonghaile T,Letai A

    更新日期:2008-12-01 00:00:00

  • Drosophila Abelson kinase mediates cell invasion and proliferation through two distinct MAPK pathways.

    abstract::The Abelson (Abl) family of non-receptor tyrosine kinases has an important role in cell morphogenesis, motility, and proliferation. Although the function of Abl has been extensively studied in leukemia, its role in epithelial cell invasion remains obscure. Using the Drosophila wing epithelium as an in vivo model syste...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.155

    authors: Singh J,Aaronson SA,Mlodzik M

    更新日期:2010-07-15 00:00:00